Geriatric nutritional risk index predicts postoperative outcomes in elderly patients with pancreatoduodenectomy: a propensity score-matched analysis
Highlight box
Key findings
• Nutritional status assessed by Geriatric Nutrition Risk Index (GNRI) predicts post-pancreatoduodenectomy (post-PD) complications in elderly patients.
What is known and what is new?
• Preoperative GNRI can predict complications after PD in elderly patients.
• As a valuable tool, GNRI is used to identify patients at risk for nutrition-related morbidity and mortality, and plays a role in predicting postoperative complications of elderly patients.
What is the implication, and what should change now?
• GNRI is a standardized nutritional screening instrument that can be utilized to assess the risk of postoperative complications for elderly patients undergoing pancreatoduodenectomy prior to the operation.
Introduction
Pancreatic cancer (PC), with an increasing incidence of approximately 1% per year, ranks as the third leading cause of cancer-related mortality, and its five-year survival rate remains as low as 13% (1). This unfavorable prognosis is primarily due to the absence of effective early detection methods and the limited efficacy of traditional therapeutic approaches (2,3). Only 15–20% of patients are eligible for potentially curative surgery (4). Pancreaticoduodenectomy (PD), primarily used to resect tumors located in the periampullary region, most of which are PCs situated in the pancreatic head, has long been considered one of the most technically demanding and impactful surgical procedures. Despite continuous technological and medical advancements leading to a reduction in postoperative mortality rates, the associated complications still significantly impact patients’ prognosis (5). Advanced age presents a significant global public health challenge. The number of elderly patients undergoing PD for tumors continues to increase (6). Despite some researchers advocating for performing PD on elderly patients with thorough preparation (7,8), there is still an ongoing debate regarding the impact of age on postoperative complications and mortality rates (6,9). Therefore, promptly identifying and stratifying elderly patients is crucial.
Malnutrition is characterized by inadequate or excessive nutrient intake, an imbalance of essential nutrients, or the impaired utilization of nutrients by the body (10,11). Cancer-associated cachexia is a multifactorial syndrome primarily characterized by the loss of muscle mass, leading to a decline in quality of life, failure of anti-cancer therapies, and other adverse outcomes (12,13). Cachexia or weight loss is significantly associated with poorer survival rates in patients with PC (14,15).
The Geriatric Nutrition Risk Index (GNRI) serves as a valuable tool for the identification of patients at risk for nutrition-related morbidity and mortality (16). This method, which incorporates albumin levels and ideal body weight (IBW), has been widely validated and is associated with frailty and various clinical results in patients (17-19). Furthermore, a previous retrospective analysis involving 106 patients demonstrated an independent association between a GNRI <94 and surgical site infection following PD (20,21). However, there are limited available data on the relationship between preoperative malnutrition in elderly patients who undergo PD and postoperative outcomes. Our aim was to investigate the association between preoperative GNRI and postoperative complications in elderly patients. We present this article in accordance with the STROBE reporting checklist (available at https://gs.amegroups.com/article/view/10.21037/gs-2024-541/rc) (22).
Methods
Study design
The study retrospectively collected data from 392 patients who underwent PD at the Department of Pancreatic Surgery in West China Hospital of Sichuan University between January 2018 and March 2023. This study was approved by the institutional review board of West China Hospital of Sichuan University (No. 2024-1386) in July 2024. Individual consent for this retrospective analysis was waived. The study was conducted in accordance with the Declaration of Helsinki and its subsequent amendments (23). The article data are accessible for research purposes up to 2 years following publication (from August 2024 to December 2026).
The inclusion criteria were as follows: (I) patients aged 65 years or older; (II) patients who underwent PD with pancreaticojejunostomy; (III) the perioperative data and pathological results were complete. Exclusion criteria: (I) patients who underwent PD combined with distal pancreatectomy or experienced multiple pancreatic injuries; (II) pancreaticojejunostomy with invagination pancreatojejunostomy or pancreaticogastrostomy; (III) intraoperative modifications in surgical techniques.
Data collection
Clinical data were collected using the electronic medical record system. Hemoglobin and hematocrit levels were reassessed on the 3rd to 5th day after surgery. The intraoperative blood loss of patients was estimated using formula proposed by Mercuriali, Inghilleri and Nadler (24,25). The calculation methods have been widely used and verified (26). The GNRI was used to assess the nutritional status of elderly patients. The patients were categorized into two groups: an at-risk group (GNRI ≤98) and a no-risk group (GNRI >98) (16). The GNRI was calculated using the following formula: [1.489 × serum albumin concentration (g/L)] + [41.7 × present body weight (PBW; kg)/IBW (kg)]. The IBW was determined by calculating height2 (m2) ×22. If the PBW exceeded the IBW, the ratio of PBW to IBW was set to 1.
Subgroup analysis
We further stratified the at-risk group based on GNRI cutoff values into high-risk group (GNRI <82), moderate-risk group (GNRI =82–91), and low-risk group (GNRI =92–98) to investigate the significance of GNRI on postoperative outcomes (27).
End points
Based on Clavien-Dindo classification, the primary outcome of the study was defined as major morbidity (Clavien-Dindo scale with ≥ grade 3b complications) (28). The secondary outcomes encompassed clinically relevant postoperative pancreatic fistula (POPF), delayed gastric emptying (DGE), and post-pancreatectomy hemorrhage (PPH), mortality rates, and length of hospital stay (LOS). POPF, DGE, and PPH were defined and classified by the International Study Group of Pancreatic Surgery (ISGPS) (29-31), and only grade B and grade C were recorded. Postoperative mortality was defined as any death that occurred during hospitalization.
Surgical procedure
The experienced surgeons performed a standard pancreatoduodenectomy (classical Whipple procedure) using either laparoscopic or open approaches. Approximately 40% of the distal stomach, pylorus, entire length of the duodenum, common bile duct, gallbladder, pancreatic head tissue with lesions on the right side of the portal vein and adjacent section of the proximal jejunum were resected. Lymph node dissection was performed around the pylorus, pancreatic head and duodenum uncinate process region as well as hepatoduodenal ligament. The consistent implementation of internal pancreatic stenting during surgery was performed for all patients due to a higher incidence of clinically relevant POPF associated with external stenting after PD (32).
Statistical analysis
Continuous variables were presented as mean (standard deviation, SD) or median (interquartile range, IQR), as appropriate. Comparisons between groups were performed by the χ2 test (categorical variables) or the Wilcoxon test (continuous variables). To control for differences between the two groups, we performed propensity score matching (PSM) (33). A conditional logistic regression model was fitted to the GNRI classification as the outcome, while age, gender, body mass index (BMI), bilirubin levels, presence of comorbidities (hypertension, diabetes, cardiac disease, pulmonary disease, and cerebral infarction), combined organ resection, type of surgical approach, and American Society of Anesthesiologists Physical Status Classification System (ASA) scores were used as covariates. Nearest-neighbor matching was performed in a 1:1 ratio with a caliper size of 0.2. Variables that showed significance at P<0.1 in univariate regression analyses underwent further evaluation through multivariate regression analyses. In this study, statistical significance was defined as P<0.05. In the subgroup analysis, we conducted analysis of variance (ANOVA) analyses for normally distributed continuous variables and Kruskal-Wallis test for non-normally distributed continuous variables across different groups. Data analysis was conducted using SPSS 26 software (SPSS Inc., Chicago, IL, USA).
Results
A total of 392 patients over 65 years of age who underwent PD were identified: 206 (52.6%) in the at-risk GNRI group and 186 (47.4%) in the no-risk GNRI group. The perioperative profiles of the two GNRI groups are described in Tables 1,2.
Table 1
Characteristics | Before PSM | After PSM | |||||
---|---|---|---|---|---|---|---|
At-risk GNRI (≤98) (n=206) | No-risk GNRI (>98) (n=186) | P value | At-risk GNRI (≤98) (n=129) | No-risk GNRI (>98) (n=129) | P value | ||
Age (years) | 71 [67–75] | 69 [67–73] | 0.03 | 70 [66.5–73] | 71 [67–74] | 0.40 | |
Male | 124 (60.2) | 111 (59.7) | 0.92 | 75 (58.1) | 79 (61.2) | 0.61 | |
BMI (kg/m2) | 20.8 [18.7–22.9] | 22.8 [21.0–24.4] | <0.001 | 21.7 [20.0–24.2] | 22.0 [20.7–23.6] | 0.81 | |
Hypertension | 57 (27.7) | 74 (39.8) | 0.01 | 41 (31.8) | 42 (32.6) | 0.90 | |
Diabetes | 42 (20.4) | 43 (23.1) | 0.51 | 27 (20.9) | 26 (20.2) | 0.88 | |
Cardiac disease | 28 (13.6) | 30 (16.1) | 0.48 | 19 (14.7) | 18 (14.0) | 0.86 | |
Cerebral infarction | 4 (1.9) | 6 (3.2) | 0.42 | 3 (2.3) | 3 (2.3) | >0.99 | |
Pulmonary disease | 45 (21.8) | 44 (23.7) | 0.67 | 28 (21.7) | 30 (23.3) | 0.77 | |
Jaundice | 122 (59.2) | 62 (33.3) | <0.001 | 55 (42.6) | 54 (41.9) | 0.80 | |
Laparoscope | 38 (18.4) | 38 (20.4) | 0.62 | 24 (18.6) | 25 (19.4) | 0.87 | |
ASA score =2 | 113 (54.9) | 112 (60.2) | 0.28 | 73 (56.6) | 75 (58.1) | 0.80 | |
Extended PD | 26 (12.6) | 29 (15.6) | 0.40 | 19 (14.7) | 19 (14.7) | >0.99 |
Data are presented as median [IQR] or number (percentage). Cardiac diseases encompass conditions such as coronary heart disease and arrhythmia; pulmonary diseases encompass conditions such as pulmonary embolism, and severe chronic obstructive pulmonary disease (which can be managed through surgery or post-treatment surgical intervention); extended PD encompasses procedures such as combined venous resection involving the portal vein or superior mesenteric vein, partial hepatectomy, or partial colectomy. ASA, American Society of Anesthesiologists Physical Status Classification System; BMI, body mass index; GNRI, Geriatric Nutrition Risk Index; IQR, interquartile range; n, number; PD, pancreaticoduodenectomy; PSM, propensity score matching.
Table 2
Characteristics | Before PSM | After PSM | |||||
---|---|---|---|---|---|---|---|
At-risk GNRI (≤98) (n=206) | No-risk GNRI (>98) (n=186) | P value | At-risk GNRI (≤98) (n=129) | No-risk GNRI (>98) (n=129) | P value | ||
Operative time (min) | 289 [234–310] | 300 [231–340] | 0.041 | 290 [240–313] | 300 [232–330] | 0.13 | |
Operative blood loss >1,000 mL | 21 (10.2) | 20 (10.8) | 0.86 | 13 (10.1) | 14 (10.9) | 0.84 | |
Pancreatic texture (hard) | 137 (66.5) | 122 (65.6) | 0.85 | 82 (63.6) | 81 (62.8) | 0.90 | |
Dilated pancreatic duct (≥3 mm) | 155 (75.2) | 144 (77.4) | 0.61 | 97 (75.2) | 102 (79.1) | 0.46 | |
Pathological outcomes (CP or PDAC) | 112 (54.4) | 113 (60.8) | 0.20 | 68 (52.7) | 77 (59.7) | 0.26 | |
Any complications | 89 (43.2) | 70 (37.6) | 0.26 | 57 (44.2) | 45 (34.9) | 0.13 | |
Major morbidity | 27 (13.1) | 13 (7.0) | 0.046 | 17 (13.2) | 7 (5.4) | 0.03 | |
Clinical related pancreatic fistula | 40 (19.4) | 33 (17.7) | 0.67 | 31 (24) | 24 (18.6) | 0.29 | |
Grade B | 37 (18.0) | 26 (14.0) | 29 (22.5) | 18 (14.0) | |||
Grade C | 3 (1.5) | 7 (3.8) | 2 (1.6) | 6 (4.7) | |||
Delayed gastric emptying | 33 (16.0) | 32 (17.2) | 0.75 | 21 (16.3) | 16 (12.4) | 0.37 | |
Grade B | 29 (14.1) | 28 (15.1) | 19 (14.7) | 14 (10.9) | |||
Grade C | 4 (1.9) | 4 (2.2) | 2 (1.6) | 2 (1.6) | |||
Post-pancreatectomy hemorrhage | 20 (9.7) | 13 (7.0) | 0.33 | 9 (7.0) | 9 (7.0) | >0.99 | |
Intra-abdominal hemorrhage | 10 (4.9) | 4 (2.2) | 2 (1.6) | 5 (3.9) | |||
Gastrointestinal hemorrhage | 15 (7.3) | 10 (5.4) | 7 (5.4) | 7 (5.4) | |||
Abdominal infection | 41 (19.9) | 31 (16.7) | 0.41 | 27 (20.9) | 23 (17.8) | 0.53 | |
Bile leakage | 3 (1.5) | 2 (1.1) | 0.74 | 1 (0.8) | 2 (1.6) | >0.99 | |
Chylous fistula | 9 (4.4) | 3 (1.6) | 0.11 | 7 (5.4) | 3 (2.3) | 0.20 | |
Pulmonary infection | 32 (15.5) | 14 (7.5) | 0.01 | 23 (17.8) | 12 (9.3) | 0.046 | |
Cardiac disease | 5 (2.4) | 3 (1.6) | 0.83 | 2 (1.6) | 1 (0.8) | >0.99 | |
Wound infection | 4 (1.9) | 4 (2.2) | >0.99 | 3 (2.3) | 3 (2.3) | >0.99 | |
Reoperation | 7 (3.4) | 10 (5.4) | 0.34 | 4 (3.1) | 7 (5.4) | 0.36 | |
30-day mortality | 2 (1.0) | 1 (0.5) | >0.99 | 0 | 1 (0.8) | >0.99 | |
Length of stay (days) | 9 [7–13] | 9 [7–13] | 0.87 | 9 [7–12] | 9 [7–14] | 0.16 |
Data are presented as median [IQR] or number (percentage). Cardiac diseases encompass conditions such as coronary heart disease and arrhythmia. CP, chronic pancreatitis; GNRI, Geriatric Nutrition Risk Index; IQR, interquartile range; n, number; PDAC, pancreatic ductal adenocarcinoma; PSM, propensity score matching.
Before stratification, the median duration of operation was 294 (IQR, 232–330) min, and there were 316 (80.6%) open surgery. Some 55 patients (14%) had extended resection and 167 of 392 patients (42.6%) were ASA scores >2. The overall postoperative morbidity rate was 59.4% (233 patients) and the major morbidity rate was 10.2% (40 patients). The median duration of postoperative hospital stay was 9 (IQR, 7–13) days.
Comparison between at-risk and no-risk GNRI in entire unmatched cohort
Age (P=0.03), BMI (P<0.001), presence of hypertension (P=0.01), and preoperative bilirubin level (P<0.001) were all significantly different between the two unmatched GNRI groups. Patients in the at-risk GNRI group exhibited advanced age, lower BMI, a higher likelihood of experiencing jaundice, and a lower prevalence of Hypertension.
In terms of clinic outcomes, patients in the at-risk GNRI group experienced a higher rate of major morbidity (13.1% vs. 7.0%, P=0.046) and pulmonary infection (15.5% vs. 7.5%, P=0.01), but a shorter operative time [median: 289 (IQR, 234–310) vs. 300 (IQR, 231–340) min].
Comparison between at-risk and no-risk GNRI in matched cohort
After 1:1 PSM, we generated 129 matched pairs between the two GNRI groups. All covariates were well balanced, with an absolute standardized difference (ASD) <0.1 and no significant differences between the groups. Patients in the at-risk GNRI group had higher rates of major complication (13.2% vs. 5.4%, P=0.03) and pulmonary infection (17.8% vs. 9.3%, P=0.046). We did not find any significant difference in rates of total morbidity, POPF, DGE, PPH, bile leakage, chylous fistula, cardiac disease, cerebral infarction, wound infection, reoperation, LOS or 30-day mortality among the two groups.
Univariate and multivariable logistic regression analysis evaluating the relationship between GNRI and major morbidity was also performed (Table 3). Advanced age [odds ratio (OR) =1.084, 95% CI: 0.989–1.189, P=0.09], increased BMI (OR =1.167, 95% CI: 0.996–1.368, P=0.056), preoperative pulmonary disease (OR =2.265, 95% CI: 0.936–5.485, P=0.07), and at-risk GNRI (OR =2.645, 95% CI: 1.058–6.617, P=0.04) were identified as significant predictors for major morbidity. In the multivariable analysis, the at-risk GNRI group exhibited a significantly higher risk for major morbidity (OR =2.698, 95% CI: 1.062–6.856, P=0.04).
Table 3
Characteristics | Univariate analysis | Multivariate analysis | |||||
---|---|---|---|---|---|---|---|
Odds ratio | 95% CI | P value | Odds ratio | 95% CI | P value | ||
Age | 1.084 | 0.989–1.189 | 0.09 | 1.071 | 0.969–1.183 | 0.18 | |
Male | 0.940 | 0.401–2.205 | 0.89 | – | – | – | |
BMI | 1.167 | 0.996–1.368 | 0.056 | 1.153 | 0.987–1.348 | 0.07 | |
Hypertension | 0.680 | 0.259–1.781 | 0.43 | – | – | – | |
Diabetes | 0.755 | 0.247–2.311 | 0.62 | – | – | – | |
Cardiac diseases | 0.239 | 0.031–1.827 | 0.17 | – | – | – | |
Cerebral infarction | 0.000 | 0.000–0.000 | >0.99 | – | – | – | |
Pulmonary disease | 2.265 | 0.936–5.485 | 0.07 | 2.040 | 0.804–5.176 | 0.13 | |
Jaundice | 0.991 | 0.423–2.324 | 0.98 | – | – | – | |
Combined organ resection | 0.812 | 0.230–2.869 | 0.75 | – | – | – | |
Laparoscope | 1.136 | 0.402–3.209 | 0.81 | – | – | – | |
ASA scores ≥3 | 1.388 | 0.598–3.219 | 0.45 | – | – | – | |
Operative time | 1.001 | 0.999–1.003 | 0.52 | – | – | – | |
Operative blood loss >1,000 mL | 1.835 | 0.577–5.833 | 0.30 | – | – | – | |
Estimated blood loss | 1.000 | 1.000–1.001 | 0.12 | – | – | – | |
Pancreatic texture (hard) | 0.662 | 0.284–1.543 | 0.34 | – | – | – | |
Pancreatic duct (≥3 mm) | 0.878 | 0.332–2.325 | 0.79 | – | – | – | |
PDAC or CP | 0.913 | 0.393–2.123 | 0.83 | – | – | – | |
At-risk GNRI | 2.645 | 1.058–6.617 | 0.04 | 2.698 | 1.062–6.856 | 0.04 |
Cardiac diseases encompass conditions such as coronary heart disease and arrhythmia; pulmonary diseases encompass conditions such as pulmonary embolism, and severe chronic obstructive pulmonary disease (which can be managed through surgery or post-treatment surgical intervention); ASA, American Society of Anesthesiologists Physical Status Classification System; BMI, body mass index; CP, chronic pancreatitis; GNRI, Geriatric Nutrition Risk Index; PDAC, pancreatic ductal adenocarcinoma.
Subgroup analysis
No statistically significant differences in baseline characteristics or clinical outcomes were observed between the groups, except for BMI, preoperative bilirubin levels, and operative time. The high-risk group had the highest incidence of jaundice (81.8%) and the lowest BMI (median 17.6; IQR, 16.2–20.2). In the high-risk group, the major mobility rate was 18.2%, in the moderate-risk group, 14.7% and in the low-risk group, 11.7%; however, no statistically significant differences were observed (Table 4).
Table 4
Characteristic | Low-risk (n=120) | Moderate-risk (n=75) | High-risk (n=11) | P value |
---|---|---|---|---|
GNRI | 95.2 [93.7–97.4] | 89.3 [87.0–90.8] | 79.2 [72.3–81.1] | <0.001 |
Age (years) | 71 [67–74] | 72 [67–76] | 71 [67–74] | 0.15 |
Male | 74 (61.7) | 44 (58.7) | 6 (54.5) | 0.85 |
BMI (kg/m2) | 21.3 [19.8–23.8] | 20.0 [18.3–22.7] | 17.6 [16.2–20.2] | 0.001 |
Hypertension | 37 (30.8) | 18 (24.0) | 2 (18.2) | 0.45 |
Diabetes | 30 (25.0) | 11 (14.7) | 1 (9.1) | 0.14 |
Cardiac disease | 12 (10.0) | 15 (20.0) | 1 (9.1) | 0.13 |
Cerebral infarction | 2 (1.7) | 2 (2.7) | 0 | 0.79 |
Pulmonary disease | 27 (22.5) | 15 (20.0) | 3 (27.3) | 0.83 |
Jaundice | 63 (52.5) | 50 (66.7) | 9 (81.8) | 0.043 |
Laparoscope | 24 (20.0) | 13 (17.3) | 1 (9.1) | 0.64 |
ASA score =2 | 66 (55.0) | 41 (54.7) | 6 (54.5) | >0.99 |
Extended PD | 16 (13.3) | 8 (10.7) | 2 (18.2) | 0.73 |
Operative time (min) | 299 [240–320] | 270 [230–300] | 240 [220–280] | 0.050 |
Estimated blood loss >1,000 mL | 12 (10.0) | 9 (12.0) | 0 | 0.47 |
Pancreatic texture (hard) | 83 (69.2) | 50 (66.7) | 4 (36.4) | 0.09 |
Dilated pancreatic duct (≥3 mm) | 89 (74.2) | 57 (76.0) | 9 (81.8) | 0.84 |
Pathological outcomes (CP or PDAC) | 70 (58.3) | 38 (50.7) | 4 (36.4) | 0.27 |
Any complications | 50 (41.7) | 34 (45.3) | 5 (45.5) | 0.87 |
Major morbidity | 14 (11.7) | 11 (14.7) | 2 (18.2) | 0.73 |
Clinical related pancreatic fistula | 22 (18.3) | 16 (21.3) | 2 (18.2) | 0.87 |
Grade B | 22 (18.3) | 15 (20) | 0 | |
Grade C | 0 | 1 (1.3) | 2 (18.2) | |
Delayed gastric emptying | 17 (14.2) | 13 (17.3) | 3 (27.3) | 0.49 |
Grade B | 15 (12.5) | 12 (16) | 2 (18.2) | |
Grade C | 2 (1.7) | 1 (1.3) | 1 (9.1) | |
Post-pancreatectomy hemorrhage | 9 (7.5) | 10 (13.3) | 1 (9.1) | 0.41 |
Intra-abdominal hemorrhage | 3 (2.5) | 7 (9.3) | 0 | |
Gastrointestinal hemorrhage | 9 (7.5) | 5 (6.7) | 1 (9.1) | |
Abdominal infection | 29 (24.2) | 10 (13.3) | 2 (18.2) | 0.18 |
Bile leakage | 1 (0.8) | 1 (1.3) | 1 (9.1) | 0.09 |
Chylous fistula | 7 (5.8) | 2 (2.7) | 0 | 0.44 |
Pulmonary infection | 16 (13.3) | 13 (17.3) | 3 (27.3) | 0.41 |
Cardiac diseases | 1 (0.8) | 3 (4.0) | 1 (9.1) | 0.13 |
Wound infection | 2 (1.7) | 1 (1.3) | 1 (9.1) | 0.21 |
Reoperation | 2 (1.7) | 4 (5.3) | 1 (9.1) | 0.22 |
30-day mortality | 2 (1.7) | 0 | 0 | 0.49 |
Length of stay (days) | 9 [7–13] | 10 [7–13] | 9 [7–12] | 0.21 |
Data are presented as median [IQR] or number (percentage). Cardiac diseases encompass conditions such as coronary heart disease and arrhythmia; pulmonary diseases encompass conditions such as pulmonary embolism, and severe COPD (which can be managed through surgery or post-treatment surgical intervention); extended PD encompasses procedures such as combined venous resection involving the portal vein or superior mesenteric vein, partial hepatectomy, or partial colectomy. ASA, American Society of Anesthesiologists Physical Status Classification System; BMI, body mass index; COPD, chronic obstructive pulmonary disease; GNRI, Geriatric Nutritional Risk Index; IQR, interquartile range; n, number; PCP, chronic pancreatitis; PD, pancreaticoduodenectomy; PDAC, pancreatic ductal adenocarcinoma.
Discussion
The number of elderly patients suffering from periampullary cancer has been on the rise worldwide. A growing number of studies have explored the clinical outcomes of elderly patients after PD, and have suggested that surgical selection should be made with caution to guarantee safety and optimize patient benefits. To mitigate confounding bias, we employed the PSM method for the first time to evaluate the predictive significance of the GNRI in elderly patients. In this study, elderly individuals categorized within the at-risk GNRI group demonstrated a heightened risk of major morbidity and postoperative pneumonia following PD, both prior to and subsequent to matching.
The surgical management of elderly patients has historically presented a complex challenge, primarily due to the increased prevalence of preoperative comorbidities and the diminished physical function that often accompany aging. Nonetheless, multiple studies have illustrated the safety and feasibility of performing PD surgery in elderly patients who meet stringent selection criteria (34,35). Miyazaki et al. conducted a retrospective analysis of 205 PD patients, stratifying them by age (≤70 vs. >70 years). The results revealed no statistically significant difference in mortality (0% vs. 1%; P=0.43) or morbidity (26% vs. 20%; P=0.41) between the two groups (36). A recent clinical trial came to similar conclusions (37). However, studies investigating age-related postoperative outcomes in PD have yielded inconsistent findings (9,38). Pineño-Flores et al. enrolled a total of 79 patients in their study (9). The ASA scores were comparable between both groups. Patients aged 75 years or older required a higher number of transfusions. There were no significant differences observed in the duration of surgery, although the elderly group underwent more vascular resections (26% vs. 8.7%; P=0.04). Morbidity was found to be higher among the elderly population (61.9% vs. 46.6%). Patients aged 75 years or older experienced more non-surgical complications (33.3%, P=0.050), with pneumonia being the most frequent complication encountered. Postoperative mortality rate was significantly higher among those aged ≥75 years compared to younger patients (9% vs. 0%; P=0.02). In a study involving 300 patients with pancreatic ductal adenocarcinoma undergoing pancreatectomy, there were no significant differences observed in terms of surgery-related complications, 30-day mortality, and LOS between the two groups. However, it was found that elderly patients had a higher prevalence of preoperative morbidity, which was associated with an increased incidence of postoperative non-surgical complications (P=0.002) (6). Hence, it is essential to identify the risk factors for severe complications in elderly patients undergoing PD.
Older patients with gastrointestinal tract-related cancers face an elevated risk of malnutrition due to obstruction or digestive dysfunction caused by the tumor (39). Furthermore, the elderly population is potentially susceptible to malnutrition, which is frequently linked to physical or psychological impairment during the aging process (40). Studies have shown that malnutrition constitutes a risk factor for postoperative complications following surgery (39,41). At present, there are several methods to assess the nutritional status of elderly patients (39), such as the Mini Nutritional Assessment, and the Nutritional Risk Screening. However, these methods have limitations due to their heavy reliance on subjective interpretation of clinical history and physical examination, leading to potential bias and time-consuming procedures. The use of these methods may not be optimal in a fast-paced surgical environment. Nevertheless, the GNRI, which is derived from readily accessible indicators such as body weight and albumin levels, demonstrates remarkable practicality for routine implementation. Furthermore, its reliability has been extensively validated across diverse pathological conditions. In relation to PD, two studies have indicated a potential association between lower GNRI levels and the occurrence of surgical site infections or post-pancreatectomy hemorrhage (20,21). In this study, we observed that patients in the at-risk group exhibited a higher prevalence of pre-operative comorbidities, including pneumonia and jaundice. One study has shown that pneumonia is associated with a significantly higher 90-day mortality rate compared to those without pneumonia (29.8% vs. 2.1%, P<0.001) and has the greatest impact on mortality after PD (OR =9.6, P<0.001) (42). The research also found that a preoperative total serum bilirubin level of ≥13 mg/dL was linked to higher mortality rates within 90 days after PD (43). Moreover, a propensity-matched study revealed that direct surgery for preoperative jaundice was linked to higher overall postoperative complication rates, including PPH and POPF, in comparison to preoperative biliary drainage (44). After matching, both groups were well balanced for all variables. The at-risk GNRI group had significantly higher rates of major complications (13.2% vs. 5.4%, P=0.03) and pulmonary infections (17.8% vs. 9.3%, P=0.046). In multivariable analysis, this group also showed a significantly increased risk for major morbidity (OR =2.698, 95% CI: 1.062–6.856, P=0.04). These results have significant implications for clinical practice, emphasizing the need to identify and address malnutrition risk factors before surgery to improve outcomes. Subsequent subgroup analysis revealed a gradual increase in the incidence of major mobility deterioration with rising risk levels; however, our study did not demonstrate a significant difference. Clinical practice often indicates that populations at higher nutritional risk are more susceptible to developing postoperative complications. This condition may be attributed to the limitations in sample size and the variations in baseline information prior to surgery. Further investigation is necessary to explore the phenomenon.
This naturally brings attention to the vital contributions of various healthcare professionals specializing in nutrition. Examples range from clinicians with advanced nutrition training to clinical nurse specialists specializing in nutrition. Clinical evidence has revealed that clinical nurse specialists in nutrition is equipped to provide expert assistance, guaranteeing superior safety, effectiveness, and care quality (45). To date, the adoption of nurse nutrition specialists remains limited globally. Training programs tailored to this profession are highly necessary(45 46).
There are certain limitations in this study. Firstly, being a retrospective study inherently introduces information and selection biases that cannot be entirely eliminated despite our utilization of the PSM method as a means to alleviate them. However, complete elimination of these biases can only be achieved through prospective randomized controlled trials. Secondly, in order to fully comprehend the influence of long-term outcomes on elderly individuals, further exploration utilizing supplementary real-world data is imperative.
Conclusions
GNRI is a standardized nutritional screening tool that can be used to preoperatively assess the risk of postoperative complications in older patients undergoing pancreatoduodenectomy. It is an independent predictor of major morbidity after pancreatoduodenectomy. The postoperative morbidity and mortality rates in elderly patients within the high-risk group appear to be comparable to those in the moderate or low-risk group. To further verify this conclusion, large-scale and prospective trials research is still needed.
Acknowledgments
None.
Footnote
Reporting Checklist: The authors have completed the STROBE reporting checklist. Available at https://gs.amegroups.com/article/view/10.21037/gs-2024-541/rc
Data Sharing Statement: Available at https://gs.amegroups.com/article/view/10.21037/gs-2024-541/dss
Peer Review File: Available at https://gs.amegroups.com/article/view/10.21037/gs-2024-541/prf
Funding: This study was supported by
Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://gs.amegroups.com/article/view/10.21037/gs-2024-541/coif). All authors report that this study was supported by the Sichuan Provincial Science and Technology Department Project (No. 23NSFSC0850) and Sichuan Province Cadres Health Research Project (Sichuan Ganyan 2023-117). The authors have no other conflicts of interest to declare.
Ethical Statement: The authors are accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. This study was approved by the institutional review board of West China Hospital of Sichuan University (No. 2024-1386) in July 2024. Individual consent for this retrospective analysis was waived. The study was conducted in accordance with the Declaration of Helsinki and its subsequent amendments.
Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.
References
- Siegel RL, Kratzer TB, Giaquinto AN, et al. Cancer statistics, 2025. CA Cancer J Clin 2025;75:10-45. [Crossref] [PubMed]
- Chakkera M, Foote JB, Farran B, et al. Breaking the stromal barrier in pancreatic cancer: Advances and challenges. Biochim Biophys Acta Rev Cancer 2024;1879:189065. [Crossref] [PubMed]
- Hu ZI, O'Reilly EM. Therapeutic developments in pancreatic cancer. Nat Rev Gastroenterol Hepatol 2024;21:7-24. [Crossref] [PubMed]
- Neoptolemos JP, Kleeff J, Michl P, et al. Therapeutic developments in pancreatic cancer: current and future perspectives. Nat Rev Gastroenterol Hepatol 2018;15:333-48. [Crossref] [PubMed]
- Uijterwijk BA, Wei K, Kasai M, et al. Minimally invasive versus open pancreatoduodenectomy for pancreatic ductal adenocarcinoma: Individual patient data meta-analysis of randomized trials. Eur J Surg Oncol 2023;49:1351-61. [Crossref] [PubMed]
- Renz BW, Khalil PN, Mikhailov M, et al. Pancreaticoduodenectomy for adenocarcinoma of the pancreatic head is justified in elderly patients: A Retrospective Cohort Study. Int J Surg 2016;28:118-25. [Crossref] [PubMed]
- Beltrame V, Gruppo M, Pastorelli D, et al. Outcome of pancreaticoduodenectomy in octogenarians: Single institution's experience and review of the literature. J Visc Surg 2015;152:279-84. [Crossref] [PubMed]
- Henry AC, Schouten TJ, Daamen LA, et al. Short- and Long-Term Outcomes of Pancreatic Cancer Resection in Elderly Patients: A Nationwide Analysis. Ann Surg Oncol 2022;29:6031-42. [Crossref] [PubMed]
- Pineño-Flores C, Ambrona-Zafra D, Rodríguez-Pino JC, et al. Cephalic pancreaticoduodenectomy for ductal adenocarcinoma in the elderly. Can we do it safely? Cir Esp (Engl Ed) 2022;100:125-32. [Crossref] [PubMed]
. Available online: https://www.who.int/health-topics/malnutrition#tab=tab_1World Health Organization - Cederholm T, Barazzoni R, Austin P, et al. ESPEN guidelines on definitions and terminology of clinical nutrition. Clin Nutr 2017;36:49-64. [Crossref] [PubMed]
- Arends J, Strasser F, Gonella S, et al. Cancer cachexia in adult patients: ESMO Clinical Practice Guidelines ESMO Open 2021;6:100092. [Crossref] [PubMed]
- Roeland EJ, Bohlke K, Baracos VE, et al. Management of Cancer Cachexia: ASCO Guideline. J Clin Oncol 2020;38:2438-53. [Crossref] [PubMed]
- Dunne RF, Crawford J, Smoyer KE, et al. The mortality burden of cachexia or weight loss in patients with colorectal or pancreatic cancer: A systematic literature review. J Cachexia Sarcopenia Muscle 2024;15:1628-40.
- Pellegrinelli A, Mancin S, Brolese A, et al. Impact of Preoperative Malnutrition on Patients with Pancreatic Neoplasms Post-Duodenopancreatectomy: A Retrospective Cohort Study. Nutrients 2024;16:1839. [Crossref] [PubMed]
- Bouillanne O, Morineau G, Dupont C, et al. Geriatric Nutritional Risk Index: a new index for evaluating at-risk elderly medical patients. Am J Clin Nutr 2005;82:777-83. [Crossref] [PubMed]
- Hanada M, Yamauchi K, Miyazaki S, et al. Geriatric Nutritional Risk Index, a predictive assessment tool, for postoperative complications after abdominal surgery: A prospective multicenter cohort study. Geriatr Gerontol Int 2019;19:924-9. [Crossref] [PubMed]
- Riveros C, Jazayeri SB, Chalfant V, et al. The Geriatric Nutritional Risk Index Predicts Postoperative Outcomes in Bladder Cancer: A Propensity Score-Matched Analysis. J Urol 2022;207:797-804. [Crossref] [PubMed]
- Yiu CY, Liu CC, Wu JY, et al. Efficacy of the Geriatric Nutritional Risk Index for Predicting Overall Survival in Patients with Head and Neck Cancer: A Meta-Analysis. Nutrients 2023;15:4348. [Crossref] [PubMed]
- Funamizu N, Omura K, Ozaki T, et al. Geriatric nutritional risk index serves as risk factor of surgical site infection after pancreatoduodenectomy: a validation cohort Ageo study. Gland Surg 2020;9:1982-8. [Crossref] [PubMed]
- Funamizu N, Omura K, Takada Y, et al. Geriatric Nutritional Risk Index Less Than 92 Is a Predictor for Late Postpancreatectomy Hemorrhage Following Pancreatoduodenectomy: A Retrospective Cohort Study. Cancers (Basel) 2020;12:2779. [Crossref] [PubMed]
- Vandenbroucke JP, von Elm E, Altman DG, et al. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. PLoS Med 2007;4:e297. [Crossref] [PubMed]
- World Medical Association Declaration of Helsinki. ethical principles for medical research involving human subjects. JAMA 2013;310:2191-4. [Crossref] [PubMed]
- Nadler SB, Hidalgo JH, Bloch T. Prediction of blood volume in normal human adults. Surgery 1962;51:224-32.
- Mercuriali F, Inghilleri G. Proposal of an algorithm to help the choice of the best transfusion strategy. Curr Med Res Opin 1996;13:465-78. [Crossref] [PubMed]
- Xu D, Liu M, Lou W, et al. Hidden blood loss and the influential factors after minimally invasive treatment of posterior pelvic ring injury with sacroiliac screw. Trials 2024;25:305. [Crossref] [PubMed]
- Tsutsui T, Fujiwara T, Matsumoto Y, et al. Geriatric nutritional risk index as the prognostic factor in older patients with fragility hip fractures. Osteoporos Int 2023;34:1207-21. [Crossref] [PubMed]
- Clavien PA, Barkun J, de Oliveira ML, et al. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg 2009;250:187-96. [Crossref] [PubMed]
- Bassi C, Marchegiani G, Dervenis C, et al. The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 Years After. Surgery 2017;161:584-91. [Crossref] [PubMed]
- Wente MN, Bassi C, Dervenis C, et al. Delayed gastric emptying (DGE) after pancreatic surgery: a suggested definition by the International Study Group of Pancreatic Surgery (ISGPS). Surgery 2007;142:761-8. [Crossref] [PubMed]
- Wente MN, Veit JA, Bassi C, et al. Postpancreatectomy hemorrhage (PPH): an International Study Group of Pancreatic Surgery (ISGPS) definition. Surgery 2007;142:20-5. [Crossref] [PubMed]
- Jang JY, Chang YR, Kim SW, et al. Randomized multicentre trial comparing external and internal pancreatic stenting during pancreaticoduodenectomy. Br J Surg 2016;103:668-75. [Crossref] [PubMed]
- Kane LT, Fang T, Galetta MS, et al. Propensity Score Matching: A Statistical Method. Clin Spine Surg 2020;33:120-2. [Crossref] [PubMed]
- Ballarin R, Esposito G, Guerrini GP, et al. Minimally Invasive Pancreaticoduodenectomy in Elderly versus Younger Patients: A Meta-Analysis. Cancers (Basel) 2024;16:323. [Crossref] [PubMed]
- Begum S, Amjad K, Shamoon M, et al. Is age just a number or does it really affect the surgical and oncological outcomes after pancreatoduodenectomy? J Pak Med Assoc 2022;72:2413-6. [Crossref] [PubMed]
- Miyazaki Y, Kokudo T, Amikura K, et al. Age does not affect complications and overall survival rate after pancreaticoduodenectomy: Single-center experience and systematic review of literature. Biosci Trends 2016;10:300-6. [Crossref] [PubMed]
- Justo Alonso I, Alonso Murillo L, Marcacuzco Quinto A, et al. Cephalic pancreatoduodenectomy in octogenarian patients with pancreatic tumors. Cir Esp (Engl Ed) 2023;101:599-608. [Crossref] [PubMed]
- Casadei R, Ricci C, Lazzarini E, et al. Pancreatic resection in patients 80 years or older: a meta-analysis and systematic review. Pancreas 2014;43:1208-18. [Crossref] [PubMed]
- Huang Y, Chen Y, Wei L, et al. Comparison of three malnutrition risk screening tools in identifying malnutrition according to Global Leadership Initiative on Malnutrition criteria in gastrointestinal cancer. Front Nutr 2022;9:959038. [Crossref] [PubMed]
- Lin YM, Wang M, Sun NX, et al. Screening and application of nutritional support in elderly hospitalized patients of a tertiary care hospital in China. PLoS One 2019;14:e0213076. [Crossref] [PubMed]
- Schaller SJ, Fuest K, Ulm B, et al. Goal-directed Perioperative Albumin Substitution Versus Standard of Care to Reduce Postoperative Complications: A Randomized Clinical Trial (SuperAdd Trial). Ann Surg 2024;279:402-9. [Crossref] [PubMed]
- Nagle RT, Leiby BE, Lavu H, et al. Pneumonia is associated with a high risk of mortality after pancreaticoduodenectomy. Surgery 2017;161:959-67. [Crossref] [PubMed]
- Chen B, Trudeau MT, Maggino L, et al. Defining the Safety Profile for Performing Pancreatoduodenectomy in the Setting of Hyperbilirubinemia. Ann Surg Oncol 2020;27:1595-605. [Crossref] [PubMed]
- Shen Z, Zhang J, Zhao S, et al. Preoperative biliary drainage of severely obstructive jaundiced patients decreases overall postoperative complications after pancreaticoduodenectomy: A retrospective and propensity score-matched analysis. Pancreatology 2020;20:529-36. [Crossref] [PubMed]
- Mancin S, Pipitone V, Testori A, et al. Clinical nurse specialists in nutrition: A systematic review of roles and clinical experiences. Int Nurs Rev 2024;71:521-30. [Crossref] [PubMed]
- Mancin S, Sguanci M, Cattani D, et al. Nutritional knowledge of nursing students: A systematic literature review. Nurse Educ Today 2023;126:105826. [Crossref] [PubMed]